Last reviewed · How we verify
ASF 1096 0.5 % cream
ASF 1096 0.5% cream is a topical corticosteroid used to reduce inflammation and itching in various skin conditions.
ASF 1096 0.5% cream is a topical corticosteroid used to reduce inflammation and itching in various skin conditions. Used for Eczema, Psoriasis, Dermatitis.
At a glance
| Generic name | ASF 1096 0.5 % cream |
|---|---|
| Sponsor | Astion Pharma A/S |
| Drug class | Topical corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
It works by suppressing the immune system's response to inflammation, thereby reducing the symptoms associated with skin conditions such as eczema, psoriasis, and dermatitis. The exact mechanism of action involves the inhibition of phospholipase A2, which is involved in the production of inflammatory mediators.
Approved indications
- Eczema
- Psoriasis
- Dermatitis
Common side effects
- Skin atrophy
- Hypersensitivity reactions
Key clinical trials
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) (PHASE2)
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ASF 1096 0.5 % cream CI brief — competitive landscape report
- ASF 1096 0.5 % cream updates RSS · CI watch RSS
- Astion Pharma A/S portfolio CI